After thirty years, we still cannot understand why methylene blue is not a reference to treat vasoplegic syndrome in cardiac surgery (2021)
- Authors:
- USP affiliated authors: EVORA, PAULO ROBERTO BARBOSA - FMRP ; MARTINS, MARIA AUXILIADORA - FMRP ; BASILE FILHO, ANIBAL - FMRP ; SILVA, FÁBIO LUIS DA - FMRP
- Unidade: FMRP
- DOI: 10.21470/1678-9741-2021-0955
- Subjects: PROCEDIMENTOS CIRÚRGICOS CARDÍACOS; HIPOTENSÃO; AZUL DE METILENO; FARMACOTERAPIA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Brazilian Journal of Cardiovascular Surgery
- ISSN: 1678-9741
- Volume/Número/Paginação/Ano: v. 36, n. 3, p. 406-411, 2021
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
EVORA, Paulo Roberto Barbosa et al. After thirty years, we still cannot understand why methylene blue is not a reference to treat vasoplegic syndrome in cardiac surgery. Brazilian Journal of Cardiovascular Surgery, v. 36, n. 3, p. 406-411, 2021Tradução . . Disponível em: https://doi.org/10.21470/1678-9741-2021-0955. Acesso em: 27 dez. 2025. -
APA
Evora, P. R. B., Soares, R. O. dos S., Bassetto, S., Martins, M. A., Silva, F. L. da, & Basile-Filho, A. (2021). After thirty years, we still cannot understand why methylene blue is not a reference to treat vasoplegic syndrome in cardiac surgery. Brazilian Journal of Cardiovascular Surgery, 36( 3), 406-411. doi:10.21470/1678-9741-2021-0955 -
NLM
Evora PRB, Soares RO dos S, Bassetto S, Martins MA, Silva FL da, Basile-Filho A. After thirty years, we still cannot understand why methylene blue is not a reference to treat vasoplegic syndrome in cardiac surgery [Internet]. Brazilian Journal of Cardiovascular Surgery. 2021 ; 36( 3): 406-411.[citado 2025 dez. 27 ] Available from: https://doi.org/10.21470/1678-9741-2021-0955 -
Vancouver
Evora PRB, Soares RO dos S, Bassetto S, Martins MA, Silva FL da, Basile-Filho A. After thirty years, we still cannot understand why methylene blue is not a reference to treat vasoplegic syndrome in cardiac surgery [Internet]. Brazilian Journal of Cardiovascular Surgery. 2021 ; 36( 3): 406-411.[citado 2025 dez. 27 ] Available from: https://doi.org/10.21470/1678-9741-2021-0955 - Clinical investigation of intestinal fatty acid-binding protein (I-FABP) as a biomarker of SARS-CoV-2 infection
- An easy way to estimate energy expenditure from hemodynamic data in septic patients
- O modo de ventilação mecânica(volume versus pressão) não altera as variáveis obtidas pela clorimetria indireta em pacientes em estado crítico
- Mechanical ventilation mode (volume x pressure) does not change the variables obtained by indirect calorimetry in critically ill patients
- Validation study of ultrasonography versus computed tomography for measuring muscle mass loss in critically ill patients [Carta]: CT mUS study
- Comparison of ultrasound with computed tomography to measure skeletal muscle mass in critically ill patients: a prospective study protocol
- Performance of microvesicles as biomarkers of clinical outcome in sepsis and trauma: a pilot study
- Effect of methylene blue on hemodynamic and metabolic response in septic shock patients
- Effect of methylene blue on hemodynamic response in the early phase of septic shock: a case series
- Estudo prospectivo, randomizado e controlado sobre os efeitos hemodinâmicos e metabólicos do azul de metileno no choque séptico
Informações sobre o DOI: 10.21470/1678-9741-2021-0955 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003072525.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
